Neurogenetic Disorders: Neurogenetics, Pathogenesis, and Gene Therapy

Dear Colleagues,

Rare neurogenetic disorders represent a profound challenge in neurology and are characterized by complexity, heterogeneity, and low prevalence. These diseases, stemming from diverse hereditary mechanisms—including autosomal dominant, autosomal recessive, X-linked, and mitochondrial inheritance—often manifest with severe, life-threatening, or chronically debilitating symptoms. Despite affecting only a small proportion of the population, they collectively impose a significant burden, with many conditions presenting at birth or during childhood.

Advances in precision medicine and gene therapy offer promising avenues for addressing these disorders. By leveraging the power of molecular genetics, researchers are uncovering pathways toward targeted, personalized interventions. This Special Issue focuses on the intersection of precision medicine, neurogenetics, and gene therapy, with an emphasis on their transformative potential in diagnosing, managing, and treating rare inherited disorders of the nervous system.

Topics of interest include innovations in gene-editing technologies, the use of biomarkers for tailored interventions, and the development of therapies targeting specific rare disorders such as mitochondrial diseases, hereditary neuropathies, motor neuron diseases, and inherited dementias. We invite submissions that explore the molecular underpinnings of these conditions and highlight breakthroughs in personalized treatments designed to improve patient outcomes.

Dr. Paschalis Theotokis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.